Extended-Spectrum Beta-Lactamase Detection with Different Panels for Automated Susceptibility Testing and with a Chromogenic Medium

被引:26
作者
Faerber, J. [1 ]
Moder, K. -A. [1 ]
Layer, F. [1 ]
Tammer, I. [1 ]
Koenig, W. [1 ]
Koenig, B. [1 ]
机构
[1] Univ Magdeburg, Inst Med Microbiol, D-39120 Magdeburg, Germany
关键词
D O I
10.1128/JCM.00777-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infections caused by extended-spectrum beta-lactamase (ESBL)- and ampC beta-lactamase-producing gram-negative bacteria complicate therapy and limit treatment options. Several different panels for ESBL detection with automated systems exist. In addition, a chromogenic agar medium is available for ESBL screening. We compared two automated identification and susceptibility testing systems with regard to their effectiveness in detecting ESBL production in Enterobacteriaceae: the BD Phoenix system (BD Diagnostic Systems, Sparks, MD) and the Vitek 2 system (bioMerieux, Marcy l'Etoile, France). We tested 114 strains using the Etest as the standard, various available panels for both automated systems (for BD Phoenix, the NMIC/ID-50 and NMIC/ID-70 GN Combo panels for combined identification and susceptibility testing of gram-negative bacilli, and for Vitek 2, the ID-GNB panel for identification of gram-negative bacilli and the AST-N020, AST-N041, and AST-N062 panels for susceptibility testing), and a chromogenic agar medium (bioMerieux, Marcy l'Etoile, France). PCR for common ESBL gene families (encoding TEM, SHV, OXA, and CTX-M) and for chromosomal or plasmid-mediated ampC beta-lactamase genes was conducted to complete the study design. For the tested specimens overall, the chromID ESBL agar showed the highest sensitivity (95.8%) but the lowest specificity (10.5%) compared to the sensitivity and specificity of the Etest (chosen as reference by the authors) for the detection of ESBL-producing strains. The BD Phoenix system showed sensitivities of 77.1% and 84.2% and specificities of 61.5% and 75.0%, respectively, for the NMIC/ID-50 andNMIC/ID-70 panels. The sensitivity of the Vitek 2 system ranged from 78.8% (AST-N020) to 80.6% (AST-N062) and up to 84.2% (AST-N041). The specificities of the respective panels were 50.0% (AST-N041 and AST-N062) and 55.6% (AST-N020). In conclusion, the sensitivities and specificities of ESBL detection by the different methods differ depending on the microorganisms under study.
引用
收藏
页码:3721 / 3727
页数:7
相关论文
共 29 条
  • [1] Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae
    Abele-Horn, M
    Stoy, K
    Frosch, M
    Reinert, RR
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) : 55 - 57
  • [2] Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci
    Abele-Horn, M
    Hommers, L
    Trabold, R
    Frosch, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (01) : 71 - 76
  • [3] ABELEHORN M, 2002, MIKROBIOLOGE, V12, P203
  • [4] Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals
    Barry, J
    Brown, A
    Ensor, V
    Lakhani, U
    Petts, D
    Warren, C
    Winstanley, T
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1191 - 1202
  • [5] Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis
    Bret, L
    Chanal-Claris, C
    Sirot, D
    Chaibi, EB
    Labia, R
    Sirot, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1110 - 1114
  • [6] Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex
    Brisse, S
    Stefani, S
    Verhoef, J
    Van Belkum, A
    Vandamme, P
    Goessens, W
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1743 - 1748
  • [7] Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum β-lactamase-producing Enterobacteriaceae
    Glupczynski, Youri
    Berhin, Catherine
    Bauraing, Caroline
    Bogaerts, Pierre
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 501 - 505
  • [8] TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS
    KNOTHE, H
    SHAH, P
    KRCMERY, V
    ANTAL, M
    MITSUHASHI, S
    [J]. INFECTION, 1983, 11 (06) : 315 - 317
  • [9] Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
    Leverstein-van Hall, MA
    Fluit, AC
    Paauw, A
    Box, ATA
    Brisse, S
    Verhoef, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3703 - 3711
  • [10] Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci
    Ligozzi, M
    Bernini, C
    Bonora, MG
    de Fatima, M
    Zuliani, J
    Fontana, R
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1681 - 1686